Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 3 study of IV lasmiditan in migraine patients

Next Previous
Trial Profile

Phase 3 study of IV lasmiditan in migraine patients

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 17 May 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lasmiditan (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms RANGER

    • Most Recent Events

    • 17 May 2016 New trial record
    • 11 May 2016 According to CoLucid Pharmaceuticals media release, company has filed an Investigational New Drug application (IND) with the FDA for IV lasmiditan and the company's clinical program may proceed when it manufactures its IV product under the FDA's current Good Manufacturing Practices (cGMP) and it submits a certificate of analysis (COA). Company has also received preliminary feedback on this trial and will be resubmitted under a request for SPA in parallel to the submission of the COA.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top